DK0969833T3 - Forlængelse af ekspressionen af transgene proteiner ved immunmodulerende behandling med 15-deoxyspergualin - Google Patents

Forlængelse af ekspressionen af transgene proteiner ved immunmodulerende behandling med 15-deoxyspergualin

Info

Publication number
DK0969833T3
DK0969833T3 DK98913712T DK98913712T DK0969833T3 DK 0969833 T3 DK0969833 T3 DK 0969833T3 DK 98913712 T DK98913712 T DK 98913712T DK 98913712 T DK98913712 T DK 98913712T DK 0969833 T3 DK0969833 T3 DK 0969833T3
Authority
DK
Denmark
Prior art keywords
expression
deoxyspergualin
elongation
transgenic
immunomodulatory therapy
Prior art date
Application number
DK98913712T
Other languages
English (en)
Inventor
Gerhard Seemann
Guenter Cichon
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0969833T3 publication Critical patent/DK0969833T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98913712T 1997-03-21 1998-03-12 Forlængelse af ekspressionen af transgene proteiner ved immunmodulerende behandling med 15-deoxyspergualin DK0969833T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19711800A DE19711800A1 (de) 1997-03-21 1997-03-21 Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung
PCT/EP1998/001438 WO1998042338A1 (de) 1997-03-21 1998-03-12 Verlängerung der expression von transgenen proteinen durch immunmodulierende behandlung

Publications (1)

Publication Number Publication Date
DK0969833T3 true DK0969833T3 (da) 2003-09-15

Family

ID=7824118

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98913712T DK0969833T3 (da) 1997-03-21 1998-03-12 Forlængelse af ekspressionen af transgene proteiner ved immunmodulerende behandling med 15-deoxyspergualin

Country Status (10)

Country Link
US (2) US20030082151A1 (da)
EP (1) EP0969833B1 (da)
JP (1) JP2001518917A (da)
AT (1) ATE241356T1 (da)
AU (1) AU6831198A (da)
DE (2) DE19711800A1 (da)
DK (1) DK0969833T3 (da)
ES (1) ES2201473T3 (da)
PT (1) PT969833E (da)
WO (1) WO1998042338A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691890B2 (en) 1998-03-11 2010-04-06 James W. Williams Anti-viral uses of leflunomide products
ATE382349T1 (de) * 1998-03-11 2008-01-15 Williams James W Antivirale verwendungen von leflunomid produkten
HUP0204069A3 (en) * 1999-12-16 2005-01-28 Teva Pharma Novel processes for making- and a new crystalline form of- leflunomide and pharmaceutical composition containing it
JP2003522133A (ja) * 1999-12-28 2003-07-22 ノバルティス アクチエンゲゼルシャフト 持続性導入遺伝子発現を実現する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
DE59407413D1 (de) * 1993-01-08 1999-01-21 Hoechst Ag Verwendung von Leflunomid zur Hemmung von Interleukin 1 beta
WO1996040170A2 (en) * 1995-06-07 1996-12-19 Procept, Inc. Metal-containing compounds and their use for inhibiting the immune response
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis

Also Published As

Publication number Publication date
AU6831198A (en) 1998-10-20
PT969833E (pt) 2003-10-31
ES2201473T3 (es) 2004-03-16
US20070191299A1 (en) 2007-08-16
WO1998042338A1 (de) 1998-10-01
US20030082151A1 (en) 2003-05-01
EP0969833B1 (de) 2003-05-28
JP2001518917A (ja) 2001-10-16
DE59808541D1 (de) 2003-07-03
DE19711800A1 (de) 1998-09-24
ATE241356T1 (de) 2003-06-15
EP0969833A1 (de) 2000-01-12

Similar Documents

Publication Publication Date Title
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
NO991951L (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
BR9006264A (pt) Derivados de aminoacidos e processo para a sua producao,medicamentos,usos de um derivado de aminoacido e processo para tratamento ou prevencao de infeccoes viroticas
DK0414275T3 (da) Fremgangsmåde til fremtilling af cycliske aminosyrederivater samt mellemprodukter
DE69731368D1 (de) Mittel zum schutz von nervenzellen
NO945034L (no) Derivater i vitamin D-serien modifisert ved 20-stilling, en fremg. for frems. av slike derivater, mellomprodukter anvendt ved fremg., farmasöytiske preparater inneholdende derivatene og deres anvendelse ved frems. av legemidler
IL119207A0 (en) Treatment of tinnitus using neuroprotective agents
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
NO20002702L (no) Tienopyrimidiner
DE29504323U1 (de) Elektrolysezelle zum Herstellen von Ozon bzw. Sauerstoff
HUP0003078A2 (hu) 5-HT3 és 5-HT4 receptorok által közvetített betegségek kezelésére alkalmazható (+)-norciszaprid
DE122011100046I1 (de) In vitro kulturprozess fur verschiedene stadien von gewebeparasiten.
KR0148213B1 (en) Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
DK0969833T3 (da) Forlængelse af ekspressionen af transgene proteiner ved immunmodulerende behandling med 15-deoxyspergualin
CA2282279A1 (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
DK656588D0 (da) Substituerede hydroxylaminer, deres fremstilling og anvendelse som laegemidler, samt ved fremstillingen anvendelige mellemprodukter og fremstilling deraf
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
NO982863L (no) Nye forbindelser med analgetisk effekt
NO921906L (no) Nye 2-amino-5-cyano-1,4-dihydropyridiner, deres fremstilling og anvendelse i legemidler
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
DK0656889T3 (da) 9-chlorprostaglandinestere og -amider og deres anvendelse ved fremstilling af lægemidler
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
NO953573L (no) Benzopyraner som kaliumkanalåpnere
NO933521L (no) Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreester samt deres pyridin-N-oksyder, fremgangsmåter for deres fremstilling og deres anvendelse som legemiddel